0Items ৳ 0

Recently added item(s) ×

Your Cart is empty

Eloxatin IV Infusion

IV Infusion
Sons of pharma plc
Generic:
Oxaliplatin
Weight:
5 mg/ml

best Price:

৳ 6,226.13
৳ 6,226.13

Generic

Oxaliplatin

Pharmacology

Oxaliplatin, a platinum-containing complex similar to cisplatin, is an alkylating agent. After intracellular hydrolysis, the platinum compound binds to DNA forming cross-links which inhibit DNA replication and transcription, resulting in cell death.

Dosage Administration

May decrease plasma levels of digoxin. May increase risk of toxicity with nephrotoxic drugs. When administered as sequential infusions, taxane derivatives (docetaxel, paclitaxel) should be administered before oxaliplatin to limit myelosuppression and enhance efficacy.

Contraindications

Fatigue, fever, pain, headache, insomnia, nausea, diarrheoa, vomiting, abdominal pain, constipation, anorexia, stomatitis, anemia, thrombocytopenia, leukopenia, aspartate and alanine transaminases increased, total bilirubin increased, peripheral neuropathy, back pain, dyspnoea, cough, oedema, chest pain, peripheral oedema, flushing , thromboembolism, dizziness, rash, alopecia , hand-foot syndrome dehydration, hypokalaemia, dyspepsia, taste perversion, flatulence, mucositis, gastroesophageal reflux, dysphagia, dysuria, neutropenia, inj site reaction, rigors, arthralgia, abnormal lacrimation, serum creatinine increased, rhinitis, epistaxis, pharyngitis, pharyngolaryngeal dysesthesia, allergic reactions, hiccup.

Side Effects

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).

Pregnancy And Lactation

Pregnancy. Peripheral neuropathy with functional impairment. Severe renal impairment.

Therapeutic

Cytotoxic Chemotherapy

Storage Conditions

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).

Use the ↺ icon to reset the image
Use the ↺ icon to reset the image
Use the ↺ icon to reset the image
Use the ↺ icon to reset the image
Use the ↺ icon to reset the image
Use the ↺ icon to reset the image